Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea flag South Korea · Delayed Price · Currency is KRW
127,000
+1,900 (1.52%)
Mar 9, 2026, 3:30 PM KST

Mezzion Pharma Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
3,858,408924,3691,153,908347,6461,932,2351,563,338
Upgrade
Market Cap Growth
337.25%-19.89%231.92%-82.01%23.60%-6.13%
Upgrade
Enterprise Value
3,840,841891,1051,093,258314,5211,903,2611,542,499
Upgrade
Last Close Price
127000.0030850.0039000.0013000.0072366.6758600.00
Upgrade
Forward PE
-71.2871.2871.2871.28151.06
Upgrade
PS Ratio
497.89107.3436.3811.3172.4954.60
Upgrade
PB Ratio
103.3220.0718.7813.2530.7727.52
Upgrade
P/TBV Ratio
108.0020.8019.2914.1231.5928.33
Upgrade
EV/Sales Ratio
-103.4834.4710.2471.4153.87
Upgrade
EV/FCF Ratio
-340.38-----
Upgrade
Debt / Equity Ratio
0.290.040.040.040.070.09
Upgrade
Net Debt / Equity Ratio
-0.47-0.59-0.91-1.19-0.69-0.77
Upgrade
Net Debt / EBITDA Ratio
1.202.024.331.452.847.22
Upgrade
Net Debt / FCF Ratio
1.561.424.852.442.805.40
Upgrade
Asset Turnover
0.100.100.430.450.330.43
Upgrade
Inventory Turnover
1.151.203.823.012.443.26
Upgrade
Quick Ratio
0.601.122.121.352.723.35
Upgrade
Current Ratio
0.881.572.511.763.473.91
Upgrade
Return on Equity (ROE)
-48.05%-36.23%-29.03%-81.54%-22.75%-27.85%
Upgrade
Return on Assets (ROA)
-12.10%-10.76%-12.39%-21.14%-13.16%-7.00%
Upgrade
Return on Invested Capital (ROIC)
-93.93%-116.73%-8454.47%-321.28%-103.59%-83.31%
Upgrade
Return on Capital Employed (ROCE)
-40.80%-30.20%-23.20%-83.50%-25.70%-12.50%
Upgrade
Earnings Yield
-0.57%-2.11%-1.10%-10.44%-0.70%-0.89%
Upgrade
FCF Yield
-0.29%-2.06%-1.00%-3.69%-0.80%-0.52%
Upgrade
Buyback Yield / Dilution
-1.06%-5.62%-5.63%-0.17%-2.63%-0.11%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.